Showing results (91-100 of 529) with videos related to

Sort By:
Pageof 53
European Heart Journal. Cardiovascular Pharmacotherapy|April 27, 2024
Effects of icosapent ethyl according to baseline residual risk in patients with atherosclerotic cardiovascular disease: results from REDUCE-ITPascal M Burger, Deepak L Bhatt, Jannick A N Dorresteijn, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|April 22, 2024
Edoxaban for 12 vs. 3 months in cancer-associated isolated distal deep vein thrombosis according to different doses: insights from the ONCO DVT studyRyuki Chatani, Yugo Yamashita, Takeshi Morimoto, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|April 24, 2024
Safety of the PCSK9 inhibitor alirocumab: insights from 47 296 patient-years of observationShaun G Goodman, Philippe Gabriel Steg, Michael Szarek, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|January 30, 2026
Net Clinical Benefit of Extended Dual Pathway Inhibition in Chronic Coronary Syndrome as Classified by the 2024 ESC Criteria: a COMPASS SubstudyMorten Würtz, Kevin Kris Warnakula Olesen, Qilong Yi, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|January 19, 2026
SGLT2 inhibitors are associated with improved long-term survival in Takotsubo syndrome: insights from large-scale real-world dataElias Rawish, Felicitas Lemmer, Katharina Kurz, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|January 8, 2025
Cholinesterase inhibitors and reduced risk of hospitalization and mortality in patients with Alzheimer's dementia and heart failureMarianne Reimers-Wessberg, Hong Xu, Johan Fastbom, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|December 11, 2023
Antithrombotic therapy in patients after transcatheter aortic valve implantation: a network meta-analysisRicky D Turgeon, Ursula M Ellis, Arden R Barry
European Heart Journal. Cardiovascular Pharmacotherapy|January 13, 2024
Effects of sodium-glucose co-transporter 2 inhibitors on heart failure events in chronic kidney disease: a systematic review and meta-analysisMarieta P Theodorakopoulou, Maria-Eleni Alexandrou, Alexandros Tsitouridis, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|January 10, 2024
Validation of a novel direct method to determine reduced adherence to atorvastatin therapyJonas Pivoriunas, Nils Tore Vethe, Einar Husebye, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|October 26, 2023
Non-steroidal anti-inflammatory drugs and risk of pulmonary embolism in patients with inflammatory joint disease-results from the nationwide Norwegian Cardio-rheuma registryEirik Ikdahl, Silvia Rollefstad, Amirhossein Kazemi, et al.
Pageof 53